Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity

Journal of Bone and Mineral Research

Volumn 27, Issue 1, 2012, Pages 160-169

  Bischoff Ferrari, Heike Annette ^a,b   Dawson Hughes, Bess ^c   Stöcklin, Elisabeth ^d   Sidelnikov, Eduard ^a   Willett, Walter Churchill ^e   Edel, John Orav ^e   Stähelin, Hannes Balthasar ^f   Wolfram, Swen ^d   Jetter, Alexander ^a   Schwager, Joseph ^d   Henschkowski, Jana ^a   Von Eckardstein, Arnold ^a   Egli, Andreas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TUFTS UNIVERSITY   (United States)

^d Research and Development   (Switzerland)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

25 hydroxyvitamin D; Blood pressure; Functional decline; Markers of immunity; Postmenopausal women; Vitamin D3

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; CALCIFEDIOL; COLECALCIFEROL; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; AGED; ARTICLE; BODY MASS; BONE STRENGTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; INNATE IMMUNITY; KNEE FUNCTION; LOWER EXTREMITY FUNCTION; MUSCULOSKELETAL FUNCTION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIFEDIOL; CALCIUM; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; IMMUNITY, INNATE; INSULIN; LOWER EXTREMITY; MIDDLE AGED; PARATHYROID HORMONE; SYSTOLE; VITAMIN D;

EID: 84555187542     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.551     Document Type: Article

References (58)

1. van Schoor NM, Visser M, Pluijm SM, Kuchuk N, Smit JH, Lips P,. Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone. 2008; 42 (2): 260-6.
2. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N,. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010; 21 (7): 1151-4.
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM,. Evaluation, treatment, and prevention of vitamin d deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96 (7): 1911-30.
4. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J,. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009; 339: b3692.
5. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J,. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009; 169 (6): 551-61.
6. Giovannucci E,. Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res. 2007; 22 (Suppl 2): V81-5. (Pubitemid 351304655)
7. Giovannucci E, Liu Y, Hollis BW, Rimm EB,. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168 (11): 1174-80. (Pubitemid 351831400)
8. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W,. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168 (12): 1340-9. (Pubitemid 351930842)
9. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC,. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007; 49 (5): 1063-9. (Pubitemid 351664326)
10. Pilz S, Henry RM, Snijder MB, van Dam RM, Nijpels G, Stehouwer CD, Tomaschitz A, Pieber TR, Dekker JM,. 25-hydroxyvitamin D is not associated with carotid intima-media thickness in older men and women. Calcif Tissue Int. 2009; 84 (5): 423-4.
11. Institute of Medicine. 2010. Dietary Reference Ranges for Calcium and Vitamin D. Available from:.
12. Henry HL, Bouillon R, Norman AW, Gallagher JC, Lips P, Heaney RP, Vieth R, Pettifor JM, Dawson-Hughes B, Lamberg-Allardt CJ, Ebeling PR,. 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2010; 121 (1-2): 4-6.
13. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC,. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010; 21 (7): 1121-32.
14. Stamp TC,. Intestinal absorption of 25-hydroxycholecalciferol. Lancet. 1974; 2 (7873): 121-3.
15. Haddad JG Jr, Rojanasathit S,. Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab. 1976; 42 (2): 284-90.
16. Francis RM, Peacock M, Storer JH, Davies AE, Brown WB, Nordin BE,. Calcium malabsorption in the elderly: the effect of treatment with oral 25-hydroxyvitamin D3. Eur J Clin Invest. 1983; 13 (5): 391-6. (Pubitemid 13014016)
17. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH,. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest. 1979; 64 (2): 655-65. (Pubitemid 9235013)
18. Peacock M, Liu G, Carey M, McClintock R, Ambrosius W, Hui S, Johnston CC,. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000; 85 (9): 3011-9.
19. Sosa M, Lainez P, Arbelo A, Navarro MC,. The effect of 25-dihydroxyvitamin D on the bone mineral metabolism of elderly women with hip fracture. Rheumatology (Oxford). 2000; 39 (11): 1263-8.
20. Stamp TC, Haddad JG, Twigg CA,. Comparison of oral 25- hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet. 1977; 1 (8026): 1341-3. (Pubitemid 8127684)
21. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF,. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. 1998; 8 (3): 222-30. (Pubitemid 28427071)
22. Garcia-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F,. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int. 1997; 60 (2): 155-9. (Pubitemid 27057499)
23. Talalaj M, Gradowska L, Marcinowska-Suchowierska E, Durlik M, Gaciong Z, Lao M,. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients. Transplant Proc. 1996; 28 (6): 3485-7. (Pubitemid 26415565)
24. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, Conzelmann M,. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003; 18 (2): 343-51. (Pubitemid 36125927)
25. Schmidt-Gayk H, Spanuth E, Kotting J, Bartl R, Felsenberg D, Pfeilschifter J, Raue F, Roth HJ,. Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med. 2004; 42 (1): 90-5. (Pubitemid 38401475)
26. Soldin OP, Dahlin JR, Gresham EG, King J, Soldin SJ,. IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone. Clin Biochem. 2008; 41 (12): 937-42.
27. Ilahi M, Armas LA, Heaney RP,. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008; 87 (3): 688-91. (Pubitemid 351364551)
28. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J,. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004; 89-90 (1-5): 387-92. (Pubitemid 38844316)
29. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP,. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110 (2): 229-38. (Pubitemid 34787360)
30. Wong MS, Delansorne R, Man RY, Vanhoutte PM,. Vitamin D derivatives acutely reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2008; 295 (1): H289-96.
31. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G,. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997; 386 (6620): 78-81. (Pubitemid 27130923)
32. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y, Shah Y, Zhu H, Dong Y,. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens. 2011; 24 (5): 557-62.
33. Simpson RU, Hershey SH, Nibbelink KA,. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol. 2007; 103 (3-5): 521-4. (Pubitemid 46420533)
34. Bouillon R, Bischoff-Ferrari H, Willett W,. Vitamin D and health: perspectives from mice and man. J Bone Miner Res. 2008; 23 (7): 974-9. (Pubitemid 351915717)
35. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C,. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001; 86 (4): 1633-7. (Pubitemid 32377290)
36. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM,. Ultraviolet B and blood pressure. Lancet. 1998; 352 (9129): 709-10. (Pubitemid 28398716)
37. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W,. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004; 19 (2): 265-9. (Pubitemid 38116740)
38. Ceglia L, da Silva Morais M, Park LK, Morris E, Harris SS, Bischoff-Ferrari HA, Fielding RA, Dawson-Hughes B,. Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol. 2010; 41 (2-3): 137-42.
39. Wang Y, Becklund BR, DeLuca HF,. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys. 2010; 494 (2): 166-77.
40. Sorensen OH, Lund B, Saltin B, Andersen RB, Hjorth L, Melsen F, Mosekilde L,. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Colch). 1979; 56 (2): 157-61. (Pubitemid 10072237)
41. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T,. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003; 144 (12): 5138-44. (Pubitemid 37476038)
42. Al-Shoha A, Qiu S, Palnitkar S, Rao DS,. Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. Endocr Pract. 2009; 15 (6): 528-33.
43. Schott GD, Wills MR,. Muscle weakness in osteomalacia. Lancet. 1976; 1 (7960): 626-9.
44. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H,. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2008; 16: 16.
45. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J,. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009; 339 (1): 339 b3692.
46. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B,. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged>or =60 y. Am J Clin Nutr. 2004; 80 (3): 752-8. (Pubitemid 41115542)
47. Kamen DL, Tangpricha V,. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010; 88 (5): 441-50.
48. Bao BY, Yao J, Lee YF,. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis. 2006; 27 (9): 1883-93. (Pubitemid 44288669)
49. Banerjee A, Damera G, Bhandare R, Gu S, Lopez-Boado Y, Panettieri R Jr, Tliba O,. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br J Pharmacol. 2008; 155 (1): 84-92.
50. Sandhu MS, Casale TB,. The role of vitamin D in asthma. Ann Allergy Asthma Immunol. 2010; 105 (3): 191-9; quiz 200-2, 217.
51. Pease JE,. Asthma, allergy and chemokines. Curr Drug Targets. 2006; 7 (1): 3-312.
52. Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, Laskey D, Sylvia JS, Hollis BW, Weiss ST, Litonjua AA,. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009; 179 (9): 765-71.
53. Zehnder D, Quinkler M, Eardley KS, Bland R, Lepenies J, Hughes SV, Raymond NT, Howie AJ, Cockwell P, Stewart PM, Hewison M,. Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int. 2008; 74 (10): 1343-53.
54. Harrington JR,. The role of MCP-1 in atherosclerosis. Stem Cells. 2000; 18 (1): 65-6. (Pubitemid 30064895)
55. Griffin MD, Xing N, Kumar R,. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003; 23: 117-45. (Pubitemid 37059719)
56. Gynther P, Toropainen S, Matilainen JM, Seuter S, Carlberg C, Vaisanen S,. Mechanism of 1alpha,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. Biochim Biophys Acta. 2011; 1813 (5): 810-8.
57. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P,. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010; 74 (23): 1852-9.
58. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Goransson LG, Omdal R,. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine. 2010; 50 (2): 175-80.